On May 19, Sunrise Group announced that the latest generation of its home sleep test, Sunrise Air, received FDA clearance. The device aids in the evaluation of obstructive sleep apnea in adults with suspected sleep-disordered breathing and expands on the capabilities of the earlier Sunrise system.
About Sunrise Air
Sunrise Air is a noninvasive, chin-worn sensor that records mandibular jaw movements during sleep. Data captured by the device are analyzed using AI-supported algorithms and compiled into a report for interpretation by a healthcare professional. The system works with one of three compatible sensors positioned on the patient’s chin.
The device is designed to be ultra-lightweight and ergonomic, and it is fully rechargeable, allowing for flexible multi-night testing without the need for disposable components.
Sunrise Air builds on the previously FDA-cleared Sunrise device with the addition of integrated sensors to broaden physiologic data collection. These include thermistors to assess airflow, an optical module to measure oxygen saturation and pulse rate, and an embedded microphone for snoring analysis. Together, these enhancements strengthen the detection of respiratory events and support assessment of respiratory effort and sleep fragmentation. The expanded data set also enables more precise differentiation between central and obstructive apneas, including in clinically complex patients.
About home sleep apnea tests
Home sleep apnea tests (HSATs) are portable devices that monitor and record key physiological parameters during sleep, such as airflow, oxygen levels, and breathing patterns. These tests provide an alternative to in-lab polysomnography by offering a more accessible and convenient option for evaluating patients in their home environment.
HSATs are commonly used in the assessment of suspected sleep apnea, allowing clinicians to gather diagnostic data outside of the sleep lab while maintaining clinical oversight of interpretation and diagnosis.
Read more industry news from the AASM.
